Another Three Centers Under the French Unicancer Framework Select RayStation
Another Three Centers Under the French Unicancer Framework Select RayStation
In total, 14 centers, out of the 20 centers that constitute the Unicancer network, as well as two public hospitals, have purchased RayStation under the Unicancer 2019/PPE019 Framework agreements (four years). RayStation and RayCare have now been selected in a new Unicancer Framework agreement (2023), which applies from STOCKHOLM, Oct. 16, 2024 /PRNewswire/ -- RaySearch Laboratories AB (publ) is pleased to announce that Institut de Cancérologie de Lorraine, Centre Jean Perrin, and Centre Hospitalier Universitaire de Limoges, have placed orders for the treatment planning system RayStation* under the Unicancer 2019 Framework agreement.
RaySearch Laboratories Ab（ 公开公司）于 2024 年 10 月 16 日在斯德哥尔摩宣布，洛林癌症研究所、让·佩兰中心和利摩日大学医院已根据 Unicancer 2019 框架协议订购了治疗计划系统 RayStation*。
Unicancer is a French hospital network exclusively specialized in oncology. It brings together 18 comprehensive cancer centers and two affiliated centers, spread across 22 hospitals in France. Annually, more than 600,000 patients are treated at a Unicancer center and across the network, 787 clinical trials are ongoing.
Unicancer 是一个专门从事肿瘤学的法国医院网络，汇集了 18 家综合癌症中心和两家附属中心，遍布法国的 22 家医院。每年，有超过 600,000 名患者在 Unicancer 中心接受治疗，整个网络中有 787 个临床试验正在进行。
The orders from Institut de Cancérologie de Lorraine, Centre Jean Perrin, and Centre Hospitalier Universitaire de Limoges were received during the summer of 2024. The total order value from the three sites was 3.2 MEUR excluding service contracts, of which about one third was recognized as revenue in Q2 and two thirds in Q3.
洛林癌症研究所、让·佩兰中心和利摩日大学医院在 2024 年夏季下订单。这三个地点的总订单价值为 3.2 百万欧元（不包括服务合同），其中约三分之一的营业收入在 Q2 中确认，而三分之二在 Q3 中确认。
In total, 14 centers, out of the 20 centers that constitute the Unicancer network, as well as two public hospitals, have purchased RayStation under the Unicancer 2019/PPE019 Framework agreements (four years). RayStation and RayCare have now been selected in a new Unicancer Framework agreement (2023), which applies from August 2024.
共有 14 个中心，共 20 个组成 Unicancer 网络的中心以及两家公立医院在 Unicancer 2019/PPE019 框架协议（四年）下购买了 RayStation。RayStation 和 RayCare 现已在新的 Unicancer 框架协议（2023 年）中被选中，在 2024 年 8 月起生效。
Johan Löf, Founder and CEO, RaySearch: "I am very happy about the agreements with these important French centers, especially since they are all comprehensive cancer centers. RayStation is an excellent starting point, but our vision is that our software should support all the disciplines included in a comprehensive cancer center."
RaySearch 的创始人兼首席执行官 Johan Löf 表示：“我对与这些重要的法国中心达成协议感到非常高兴，尤其是它们都是综合癌症中心。RayStation 是一个很好的起点，但我们的愿景是，我们的软件应该支持综合癌症中心中涵盖的所有学科。”
* Subject to regulatory clearance in some markets.
* 在一些市场上需要获得监管批准。
FOR MORE INFORMATION, PLEASE CONTACT:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00
[email protected]
如需更多资讯，请联系：
Johan Löf，创始人兼首席执行官，RaySearch Laboratories Ab (publ)
电话：+46 (0) 8 510 530 00
[email protected]
Learn more about us on:
LinkedIn
YouTube
了解更多关于我们的信息：
LinkedIn
YouTube
This information was brought to you by Cision
本信息由Cision提供
The following files are available for download:
以下文件可供下载：
|
RaySearch Press Release October 16, 2024 |
|
|
Press-release 1200x620 Unicancer |
|
RaySearch 2024年10月16日新闻发布 |
|
|
新闻发布 1200x620 Unicancer |
SOURCE RaySearch Laboratories
来源： RaySearch Laboratories
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
想要您公司的新闻在PRNEWSWIRE.COM上特色呈现吗？
